▶ 調査レポート

男性ホルモン補充療法の世界市場:動向・シェア・規模・予測

• 英文タイトル:Testosterone Replacement Therapy Market by Product Type (Oral implants, Injections, Patches, Creams/Gels, Gums/Buccal Adhesives, and Others), Active Ingredients (Testosterone, Methyl Testosterone, Testosterone Cypionate, Testosterone Undecanoate, Testosterone Enanthate), End User (Hospitals, Homecare, Specialty Clinics, and Others), and Region 2023-2028

IMARCが調査・発行した産業分析レポートです。男性ホルモン補充療法の世界市場:動向・シェア・規模・予測 / Testosterone Replacement Therapy Market by Product Type (Oral implants, Injections, Patches, Creams/Gels, Gums/Buccal Adhesives, and Others), Active Ingredients (Testosterone, Methyl Testosterone, Testosterone Cypionate, Testosterone Undecanoate, Testosterone Enanthate), End User (Hospitals, Homecare, Specialty Clinics, and Others), and Region 2023-2028 / MRC-IM30951資料のイメージです。• レポートコード:MRC-IM30951
• 出版社/出版日:IMARC / 2023年3月
• レポート形態:英文、PDF、143ページ
• 納品方法:Eメール
• 産業分類:医療
• 販売価格(消費税別)
  Single User¥349,860 (USD2,499)▷ お問い合わせ
  Enterprisewide¥629,860 (USD4,499)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
グローバル調査会社のIMARC社は、2022年19億ドルであった世界の男性ホルモン補充療法市場規模が2028年には24億ドルに達し、予測期間中(2023年-2028年)、年平均3.7%成長すると予測しています。当調査資料では、男性ホルモン補充療法の世界市場を調査・分析し、序論、範囲・調査手法、エグゼクティブサマリー、イントロダクション、製品タイプ別(経口剤、注射剤、パッチ、クリーム/ゲル、その他)分析、有効成分別(テストステロン、メチルテストステロン、シピオン酸テストステロン、ウンデカン酸テストステロン、エナント酸テストステロン)分析、エンドユーザー別(病院、ホームケア、専門クリニック、その他)分析、地域別(北米、アジア、欧州、中南米、中東/アフリカ)分析、要因・制約・機会、バリューチェーン分析、ファイブフォース分析、価格分析、競争状況などの項目を掲載しています。なお、当市場の主要企業には、AbbVie Inc.、Acerus Pharmaceuticals Corporation、Antares Pharma Inc. (Halozyme Therapeutics)、Clarus Therapeutics Inc.、Endo International plc、Ferring Pharmaceuticals、Kyowa Kirin Co. Ltd.、Lupin Limited、Pfizer Inc.、Sun Pharmaceutical Industries Ltd.、Teva Pharmaceuticals USA Inc. (Teva Pharmaceutical Industries Ltd.)、Upsher-Smith Laboratories LLC (Sawai Pharmaceutical Co. Ltd.)などが含まれています。
・序論
・範囲・調査手法
・エグゼクティブサマリー
・イントロダクション

・世界の男性ホルモン補充療法市場規模:製品タイプ別
- 経口剤の市場規模
- 注射剤の市場規模
- パッチの市場規模
- クリーム/ゲルの市場規模
- その他製品タイプの市場規模

・世界の男性ホルモン補充療法市場規模:有効成分別
- テストステロンの市場規模
- メチルテストステロンの市場規模
- シピオン酸テストステロンの市場規模
- ウンデカン酸テストステロンの市場規模
- エナント酸テストステロンの市場規模

・世界の男性ホルモン補充療法市場規模:エンドユーザー別
- 病院における市場規模
- ホームケアにおける市場規模
- 専門クリニックにおける市場規模
- その他エンドユーザーにおける市場規模

・世界の男性ホルモン補充療法市場規模:地域別
- 北米の男性ホルモン補充療法市場規模
- アジアの男性ホルモン補充療法市場規模
- 欧州の男性ホルモン補充療法市場規模
- 中南米の男性ホルモン補充療法市場規模
- 中東/アフリカの男性ホルモン補充療法市場規模

・要因・制約・機会
・バリューチェーン分析
・ファイブフォース分析
・価格分析
・競争状況

Market Overview
The global testosterone replacement therapy market size reached US$ 1.9 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 2.4 Billion by 2028, exhibiting a growth rate (CAGR) of 3.7% during 2023-2028. The increasing prevalence of erectile dysfunction and hypogonadism, especially amongst the geriatric men population, and the growing consumer awareness regarding the availability of testosterone substitute therapies and their several advantages represent some of the key factors driving the market.

Testosterone replacement therapy (TRT) refers to a form of reasonable androgen treatment that helps replenish and improve the indications and symptoms associated with lower testosterone levels in men. It involves the administration of various gels, androderm patches, methyltestosterone capsules, topicals, oral implants, buccal adhesives, boosters, and injectables as some of the standard prescribed therapies. These medications help produce red blood cells (RBCs), maintain strong cardiovascular and endothelial health, improve lean muscles, increase bone density, restore libido, enhance bone mineral density, and develop a sense of well-being. Along with this, they boost cognition and memory, increase energy levels and improve overall sexual functions. Based on these properties, TRT is extensively used by prescribed patients to treat or rectify hypogonadism, autoimmune conditions, low testosterone levels, and erectile dysfunctions.

Testosterone Replacement Therapy Market Trends:
The increasing prevalence of erectile dysfunction and hypogonadism, especially amongst the geriatric men population, due to hypothalamic, pituitary axis dysfunction and testicular failures represents one of the prime factors driving the market growth. Additionally, the rising consumer awareness regarding the availability of testosterone substitute therapies to treat hormonal imbalances and their several advantages are acting as another growth-inducing factor. These treatments lower bad cholesterol levels, decrease the risk of diabetes, reduce body fat and increase the self-esteem of an individual; therefore, TRT is widely recommended to patients suffering from hypogonadism. Moreover, the favorable initiatives being undertaken by regulatory bodies to provide access to diverse TRT diagnostic and treatment solutions and the ongoing approvals of a series of medications by the regulatory authorities are favoring the market growth. In line with this, significant technological advancements, such as the extensive usage of advanced machines to formulate oral undecanoate soft gelatin capsules, are supporting the market growth. Furthermore, the continuous sensitization of the masses by non-governmental organizations (NGOs) regarding the symptoms and treatments of testosterone dysfunction is propelling the market growth. Apart from this, the large-scale product diversification and the extensive research and development (R&D) activities to enhance treatment efficacy are creating a positive outlook for the market.

Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each segment of the global testosterone replacement therapy market, along with forecasts at the global, regional, and country levels from 2023-2028. Our report has categorized the market based on product type, active ingredients, and end user.

Product Type Insights:
Oral implants
Injections
Patches
Creams/Gels
Gums/Buccal Adhesives
Others

The report has also provided a detailed breakup and analysis of the testosterone replacement therapy market based on the product type. This includes oral implants, injections, patches, creams/gels, gums/buccal adhesives, and others. According to the report, injections represented the largest segment.

Active Ingredients Insights:
Testosterone
Methyl Testosterone
Testosterone Cypionate
Testosterone Undecanoate
Testosterone Enanthate

A detailed breakup and analysis of the testosterone replacement therapy market based on the active ingredients have also been provided in the report. This includes testosterone, methyl testosterone, testosterone cypionate, testosterone undecanoate, and testosterone enanthate. According to the report, testosterone accounted for the largest market share.

End User Insights:
Hospitals
Homecare
Specialty Clinics
Others

The report has also provided a detailed breakup and analysis of the testosterone replacement therapy market based on the end user. This includes hospitals, homecare, specialty clinics, and others. According to the report, specialty clinics represented the largest segment.

Regional Insights:
North America
United States
Canada
Asia Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa

The report has also provided a comprehensive analysis of all the major regional markets that include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest market for testosterone replacement therapy. Some of the factors driving the North America testosterone replacement therapy market included the increasing prevalence of erectile dysfunction and hypogonadism, expanding geriatric population base, and the rising consumer awareness regarding the availability of testosterone substitute therapies.

Competitive Landscape:
The report has also provided a comprehensive analysis of the competitive landscape in the global testosterone replacement therapy market. Detailed profiles of all major companies have also been provided. Some of the companies covered include AbbVie Inc., Acerus Pharmaceuticals Corporation, Antares Pharma Inc. (Halozyme Therapeutics), Clarus Therapeutics Inc., Endo International plc, Ferring Pharmaceuticals, Kyowa Kirin Co. Ltd., Lupin Limited, Pfizer Inc., Sun Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA Inc. (Teva Pharmaceutical Industries Ltd.), Upsher-Smith Laboratories LLC (Sawai Pharmaceutical Co. Ltd.), etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

Key Questions Answered in This Report:
How has the global testosterone replacement therapy market performed so far and how will it perform in the coming years?
What are the drivers, restraints, and opportunities in the global testosterone replacement therapy market?
What are the key regional markets?
Which countries represent the most attractive testosterone replacement therapy markets?
What is the breakup of the market based on the product type?
What is the breakup of the market based on the active ingredients?
What is the breakup of the market based on the end user?
What is the competitive structure of the global testosterone replacement therapy market?
Who are the key players/companies in the global testosterone replacement therapy market?

レポート目次

1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Testosterone Replacement Therapy Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Product Type
6.1 Oral Implants
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Injections
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Patches
6.3.1 Market Trends
6.3.2 Market Forecast
6.4 Creams/Gels
6.4.1 Market Trends
6.4.2 Market Forecast
6.5 Gums/Buccal Adhesives
6.5.1 Market Trends
6.5.2 Market Forecast
6.6 Others
6.6.1 Market Trends
6.6.2 Market Forecast
7 Market Breakup by Active Ingredients
7.1 Testosterone
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Methyl Testosterone
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Testosterone Cypionate
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Testosterone Undecanoate
7.4.1 Market Trends
7.4.2 Market Forecast
7.5 Testosterone Enanthate
7.5.1 Market Trends
7.5.2 Market Forecast
8 Market Breakup by End User
8.1 Hospitals
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Homecare
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Specialty Clinics
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Others
8.4.1 Market Trends
8.4.2 Market Forecast
9 Market Breakup by Region
9.1 North America
9.1.1 United States
9.1.1.1 Market Trends
9.1.1.2 Market Forecast
9.1.2 Canada
9.1.2.1 Market Trends
9.1.2.2 Market Forecast
9.2 Asia-Pacific
9.2.1 China
9.2.1.1 Market Trends
9.2.1.2 Market Forecast
9.2.2 Japan
9.2.2.1 Market Trends
9.2.2.2 Market Forecast
9.2.3 India
9.2.3.1 Market Trends
9.2.3.2 Market Forecast
9.2.4 South Korea
9.2.4.1 Market Trends
9.2.4.2 Market Forecast
9.2.5 Australia
9.2.5.1 Market Trends
9.2.5.2 Market Forecast
9.2.6 Indonesia
9.2.6.1 Market Trends
9.2.6.2 Market Forecast
9.2.7 Others
9.2.7.1 Market Trends
9.2.7.2 Market Forecast
9.3 Europe
9.3.1 Germany
9.3.1.1 Market Trends
9.3.1.2 Market Forecast
9.3.2 France
9.3.2.1 Market Trends
9.3.2.2 Market Forecast
9.3.3 United Kingdom
9.3.3.1 Market Trends
9.3.3.2 Market Forecast
9.3.4 Italy
9.3.4.1 Market Trends
9.3.4.2 Market Forecast
9.3.5 Spain
9.3.5.1 Market Trends
9.3.5.2 Market Forecast
9.3.6 Russia
9.3.6.1 Market Trends
9.3.6.2 Market Forecast
9.3.7 Others
9.3.7.1 Market Trends
9.3.7.2 Market Forecast
9.4 Latin America
9.4.1 Brazil
9.4.1.1 Market Trends
9.4.1.2 Market Forecast
9.4.2 Mexico
9.4.2.1 Market Trends
9.4.2.2 Market Forecast
9.4.3 Others
9.4.3.1 Market Trends
9.4.3.2 Market Forecast
9.5 Middle East and Africa
9.5.1 Market Trends
9.5.2 Market Breakup by Country
9.5.3 Market Forecast
10 Drivers, Restraints, and Opportunities
10.1 Overview
10.2 Drivers
10.3 Restraints
10.4 Opportunities
11 Value Chain Analysis
12 Porters Five Forces Analysis
12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes
13 Price Analysis
14 Competitive Landscape
14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
14.3.1 AbbVie Inc.
14.3.1.1 Company Overview
14.3.1.2 Product Portfolio
14.3.1.3 Financials
14.3.1.4 SWOT Analysis
14.3.2 Acerus Pharmaceuticals Corporation
14.3.2.1 Company Overview
14.3.2.2 Product Portfolio
14.3.3 Antares Pharma Inc. (Halozyme Therapeutics)
14.3.3.1 Company Overview
14.3.3.2 Product Portfolio
14.3.3.3 SWOT Analysis
14.3.4 Clarus Therapeutics Inc.
14.3.4.1 Company Overview
14.3.4.2 Product Portfolio
14.3.4.3 Financials
14.3.5 Endo International plc
14.3.5.1 Company Overview
14.3.5.2 Product Portfolio
14.3.5.3 Financials
14.3.5.4 SWOT Analysis
14.3.6 Ferring Pharmaceuticals
14.3.6.1 Company Overview
14.3.6.2 Product Portfolio
14.3.7 Kyowa Kirin Co. Ltd.
14.3.7.1 Company Overview
14.3.7.2 Product Portfolio
14.3.7.3 Financials
14.3.7.4 SWOT Analysis
14.3.8 Lupin Limited
14.3.8.1 Company Overview
14.3.8.2 Product Portfolio
14.3.8.3 Financials
14.3.8.4 SWOT Analysis
14.3.9 Pfizer Inc.
14.3.9.1 Company Overview
14.3.9.2 Product Portfolio
14.3.9.3 Financials
14.3.9.4 SWOT Analysis
14.3.10 Sun Pharmaceutical Industries Ltd.
14.3.10.1 Company Overview
14.3.10.2 Product Portfolio
14.3.10.3 Financials
14.3.10.4 SWOT Analysis
14.3.11 Teva Pharmaceuticals USA Inc. (Teva Pharmaceutical Industries Ltd.)
14.3.11.1 Company Overview
14.3.11.2 Product Portfolio
14.3.12 Upsher-Smith Laboratories LLC (Sawai Pharmaceutical Co. Ltd.)
14.3.12.1 Company Overview
14.3.12.2 Product Portfolio

Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

Figure 1: Global: Testosterone Replacement Therapy Market: Major Drivers and Challenges
Figure 2: Global: Testosterone Replacement Therapy Market: Sales Value (in Billion US$), 2017-2022
Figure 3: Global: Testosterone Replacement Therapy Market Forecast: Sales Value (in Billion US$), 2023-2028
Figure 4: Global: Testosterone Replacement Therapy Market: Breakup by Product Type (in %), 2022
Figure 5: Global: Testosterone Replacement Therapy Market: Breakup by Active Ingredients (in %), 2022
Figure 6: Global: Testosterone Replacement Therapy Market: Breakup by End User (in %), 2022
Figure 7: Global: Testosterone Replacement Therapy Market: Breakup by Region (in %), 2022
Figure 8: Global: Testosterone Replacement Therapy (Oral Implants) Market: Sales Value (in Million US$), 2017 & 2022
Figure 9: Global: Testosterone Replacement Therapy (Oral Implants) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 10: Global: Testosterone Replacement Therapy (Injections) Market: Sales Value (in Million US$), 2017 & 2022
Figure 11: Global: Testosterone Replacement Therapy (Injections) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 12: Global: Testosterone Replacement Therapy (Patches) Market: Sales Value (in Million US$), 2017 & 2022
Figure 13: Global: Testosterone Replacement Therapy (Patches) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 14: Global: Testosterone Replacement Therapy (Creams/Gels) Market: Sales Value (in Million US$), 2017 & 2022
Figure 15: Global: Testosterone Replacement Therapy (Creams/Gels) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 16: Global: Testosterone Replacement Therapy (Gums/Buccal Adhesives) Market: Sales Value (in Million US$), 2017 & 2022
Figure 17: Global: Testosterone Replacement Therapy (Gums/Buccal Adhesives) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 18: Global: Testosterone Replacement Therapy (Other Product Types) Market: Sales Value (in Million US$), 2017 & 2022
Figure 19: Global: Testosterone Replacement Therapy (Other Product Types) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 20: Global: Testosterone Replacement Therapy (Testosterone) Market: Sales Value (in Million US$), 2017 & 2022
Figure 21: Global: Testosterone Replacement Therapy (Testosterone) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 22: Global: Testosterone Replacement Therapy (Methyl Testosterone) Market: Sales Value (in Million US$), 2017 & 2022
Figure 23: Global: Testosterone Replacement Therapy (Methyl Testosterone) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 24: Global: Testosterone Replacement Therapy (Testosterone Cypionate) Market: Sales Value (in Million US$), 2017 & 2022
Figure 25: Global: Testosterone Replacement Therapy (Testosterone Cypionate) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 26: Global: Testosterone Replacement Therapy (Testosterone Undecanoate) Market: Sales Value (in Million US$), 2017 & 2022
Figure 27: Global: Testosterone Replacement Therapy (Testosterone Undecanoate) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 28: Global: Testosterone Replacement Therapy (Testosterone Enanthate) Market: Sales Value (in Million US$), 2017 & 2022
Figure 29: Global: Testosterone Replacement Therapy (Testosterone Enanthate) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 30: Global: Testosterone Replacement Therapy (Hospitals) Market: Sales Value (in Million US$), 2017 & 2022
Figure 31: Global: Testosterone Replacement Therapy (Hospitals) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 32: Global: Testosterone Replacement Therapy (Homecare) Market: Sales Value (in Million US$), 2017 & 2022
Figure 33: Global: Testosterone Replacement Therapy (Homecare) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 34: Global: Testosterone Replacement Therapy (Specialty Clinics) Market: Sales Value (in Million US$), 2017 & 2022
Figure 35: Global: Testosterone Replacement Therapy (Specialty Clinics) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 36: Global: Testosterone Replacement Therapy (Other End Users) Market: Sales Value (in Million US$), 2017 & 2022
Figure 37: Global: Testosterone Replacement Therapy (Other End Users) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 38: North America: Testosterone Replacement Therapy Market: Sales Value (in Million US$), 2017 & 2022
Figure 39: North America: Testosterone Replacement Therapy Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 40: United States: Testosterone Replacement Therapy Market: Sales Value (in Million US$), 2017 & 2022
Figure 41: United States: Testosterone Replacement Therapy Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 42: Canada: Testosterone Replacement Therapy Market: Sales Value (in Million US$), 2017 & 2022
Figure 43: Canada: Testosterone Replacement Therapy Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 44: Asia-Pacific: Testosterone Replacement Therapy Market: Sales Value (in Million US$), 2017 & 2022
Figure 45: Asia-Pacific: Testosterone Replacement Therapy Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 46: China: Testosterone Replacement Therapy Market: Sales Value (in Million US$), 2017 & 2022
Figure 47: China: Testosterone Replacement Therapy Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 48: Japan: Testosterone Replacement Therapy Market: Sales Value (in Million US$), 2017 & 2022
Figure 49: Japan: Testosterone Replacement Therapy Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 50: India: Testosterone Replacement Therapy Market: Sales Value (in Million US$), 2017 & 2022
Figure 51: India: Testosterone Replacement Therapy Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 52: South Korea: Testosterone Replacement Therapy Market: Sales Value (in Million US$), 2017 & 2022
Figure 53: South Korea: Testosterone Replacement Therapy Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 54: Australia: Testosterone Replacement Therapy Market: Sales Value (in Million US$), 2017 & 2022
Figure 55: Australia: Testosterone Replacement Therapy Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 56: Indonesia: Testosterone Replacement Therapy Market: Sales Value (in Million US$), 2017 & 2022
Figure 57: Indonesia: Testosterone Replacement Therapy Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 58: Others: Testosterone Replacement Therapy Market: Sales Value (in Million US$), 2017 & 2022
Figure 59: Others: Testosterone Replacement Therapy Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 60: Europe: Testosterone Replacement Therapy Market: Sales Value (in Million US$), 2017 & 2022
Figure 61: Europe: Testosterone Replacement Therapy Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 62: Germany: Testosterone Replacement Therapy Market: Sales Value (in Million US$), 2017 & 2022
Figure 63: Germany: Testosterone Replacement Therapy Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 64: France: Testosterone Replacement Therapy Market: Sales Value (in Million US$), 2017 & 2022
Figure 65: France: Testosterone Replacement Therapy Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 66: United Kingdom: Testosterone Replacement Therapy Market: Sales Value (in Million US$), 2017 & 2022
Figure 67: United Kingdom: Testosterone Replacement Therapy Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 68: Italy: Testosterone Replacement Therapy Market: Sales Value (in Million US$), 2017 & 2022
Figure 69: Italy: Testosterone Replacement Therapy Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 70: Spain: Testosterone Replacement Therapy Market: Sales Value (in Million US$), 2017 & 2022
Figure 71: Spain: Testosterone Replacement Therapy Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 72: Russia: Testosterone Replacement Therapy Market: Sales Value (in Million US$), 2017 & 2022
Figure 73: Russia: Testosterone Replacement Therapy Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 74: Others: Testosterone Replacement Therapy Market: Sales Value (in Million US$), 2017 & 2022
Figure 75: Others: Testosterone Replacement Therapy Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 76: Latin America: Testosterone Replacement Therapy Market: Sales Value (in Million US$), 2017 & 2022
Figure 77: Latin America: Testosterone Replacement Therapy Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 78: Brazil: Testosterone Replacement Therapy Market: Sales Value (in Million US$), 2017 & 2022
Figure 79: Brazil: Testosterone Replacement Therapy Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 80: Mexico: Testosterone Replacement Therapy Market: Sales Value (in Million US$), 2017 & 2022
Figure 81: Mexico: Testosterone Replacement Therapy Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 82: Others: Testosterone Replacement Therapy Market: Sales Value (in Million US$), 2017 & 2022
Figure 83: Others: Testosterone Replacement Therapy Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 84: Middle East and Africa: Testosterone Replacement Therapy Market: Sales Value (in Million US$), 2017 & 2022
Figure 85: Middle East and Africa: Testosterone Replacement Therapy Market: Breakup by Country (in %), 2022
Figure 86: Middle East and Africa: Testosterone Replacement Therapy Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 87: Global: Testosterone Replacement Therapy Industry: Drivers, Restraints, and Opportunities
Figure 88: Global: Testosterone Replacement Therapy Industry: Value Chain Analysis
Figure 89: Global: Testosterone Replacement Therapy Industry: Porter's Five Forces Analysis